Published in ACS Biomater Sci Eng on March 03, 2016
Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol (2007) 17.80
Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm (2008) 7.67
The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci U S A (2008) 7.06
Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet (2003) 6.95
Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol (2007) 6.85
Design and development of polymers for gene delivery. Nat Rev Drug Discov (2005) 6.79
Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent. Biochem J (1978) 5.40
Stimuli-responsive nanocarriers for drug delivery. Nat Mater (2013) 3.52
Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev (2013) 3.44
Non-viral vectors for gene-based therapy. Nat Rev Genet (2014) 3.04
Targeted drug delivery to tumors: myths, reality and possibility. J Control Release (2011) 2.69
Gene therapy clinical trials worldwide to 2012 - an update. J Gene Med (2013) 2.57
Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials (2008) 2.43
PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles. Eur J Cell Biol (2004) 2.32
Immune responses to gene therapy vectors: influence on vector function and effector mechanisms. Gene Ther (2004) 2.04
Non-viral gene delivery systems. Curr Opin Biotechnol (2002) 2.00
Fluorescent nanorods and nanospheres for real-time in vivo probing of nanoparticle shape-dependent tumor penetration. Angew Chem Int Ed Engl (2011) 1.93
Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors. Hum Gene Ther (2006) 1.83
Tumor-specific imaging through progression elevated gene-3 promoter-driven gene expression. Nat Med (2010) 1.81
Non-viral gene therapy: polycation-mediated DNA delivery. Appl Microbiol Biotechnol (2003) 1.77
Barriers to nonviral gene delivery. J Pharm Sci (2003) 1.77
A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma. Adv Drug Deliv Rev (2010) 1.76
Particle shape enhances specificity of antibody-displaying nanoparticles. Proc Natl Acad Sci U S A (2013) 1.63
Gene therapy progress and prospects: synthetic polymer-based systems. Gene Ther (2008) 1.58
A nanoparticle formulation that selectively transfects metastatic tumors in mice. Proc Natl Acad Sci U S A (2013) 1.55
Polyethylenimine-graft-poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system. Bioconjug Chem (2002) 1.55
In situ quantitative monitoring of polyplexes and polyplex micelles in the blood circulation using intravital real-time confocal laser scanning microscopy. J Control Release (2011) 1.55
Expression of hemidesmosomal and extracellular matrix proteins by normal and malignant human prostate tissue. Am J Pathol (1995) 1.49
Strategies for advancing cancer nanomedicine. Nat Mater (2013) 1.48
Polyethylenimine-based intravenous delivery of transgenes to mouse lung. Gene Ther (1998) 1.45
Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium. Proc Natl Acad Sci U S A (2013) 1.37
Subtraction hybridization identifies a transformation progression-associated gene PEG-3 with sequence homology to a growth arrest and DNA damage-inducible gene. Proc Natl Acad Sci U S A (1997) 1.36
The role of alpha 6 integrin in prostate cancer migration and bone pain in a novel xenograft model. PLoS One (2008) 1.31
Facing the truth about nanotechnology in drug delivery. ACS Nano (2013) 1.30
Systemic delivery of DNA or siRNA mediated by linear polyethylenimine (L-PEI) does not induce an inflammatory response. Pharm Res (2008) 1.28
Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI). J Gene Med (2000) 1.27
Viral vectors: from virology to transgene expression. Br J Pharmacol (2009) 1.19
Targeting gene expression selectively in cancer cells by using the progression-elevated gene-3 promoter. Proc Natl Acad Sci U S A (2005) 1.17
Novel polyethylenimine-derived nanoparticles for in vivo gene delivery. Expert Opin Drug Deliv (2012) 1.16
Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy. Biomacromolecules (2014) 1.14
Polyion complex micelles as vectors in gene therapy--pharmacokinetics and in vivo gene transfer. Gene Ther (2002) 1.13
Intratumoral CC chemokine ligand 5 overexpression delays tumor growth and increases tumor cell infiltration. J Immunol (2004) 1.10
Overcoming nonviral gene delivery barriers: perspective and future. Mol Pharm (2013) 1.10
Different strategies for formation of pegylated EGF-conjugated PEI/DNA complexes for targeted gene delivery. Bioconjug Chem (2001) 1.10
Epidermal growth factor receptor-targeted (131)I-therapy of liver cancer following systemic delivery of the sodium iodide symporter gene. Mol Ther (2011) 1.07
Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells. Nanoscale (2014) 1.06
Specific alterations in the expression of alpha 3 beta 1 and alpha 6 beta 4 integrins in highly invasive and metastatic variants of human prostate carcinoma cells selected by in vitro invasion through reconstituted basement membrane. Clin Exp Metastasis (1993) 1.06
Degradable polyethylenimines as DNA and small interfering RNA carriers. Expert Opin Drug Deliv (2009) 1.04
Plasmid-templated shape control of condensed DNA-block copolymer nanoparticles. Adv Mater (2012) 1.02
Cell-specific delivery of genes with glycosylated carriers. Adv Drug Deliv Rev (2001) 1.01
A systematic analysis of peptide linker length and liposomal polyethylene glycol coating on cellular uptake of peptide-targeted liposomes. ACS Nano (2013) 0.96
Tumor-directed gene therapy in mice using a composite nonviral gene delivery system consisting of the piggyBac transposon and polyethylenimine. BMC Cancer (2009) 0.91
Rad51 promoter-targeted gene therapy is effective for in vivo visualization and treatment of cancer. Mol Ther (2011) 0.90
Progress and prospects of polyplex nanomicelles for plasmid DNA delivery. Curr Gene Ther (2011) 0.88
AEG-1 promoter-mediated imaging of prostate cancer. Cancer Res (2014) 0.86
Charge density and molecular weight of polyphosphoramidate gene carrier are key parameters influencing its DNA compaction ability and transfection efficiency. Biomacromolecules (2010) 0.86
Short laminin peptide for improved neural stem cell growth. Stem Cells Transl Med (2014) 0.86
Synergistic effect of low cytotoxic linear polyethylenimine and multiarm polyethylene glycol: study of physicochemical properties and in vitro gene transfection. Mol Pharm (2009) 0.85
Targeted gene delivery by polyplex micelles with crowded PEG palisade and cRGD moiety for systemic treatment of pancreatic tumors. Biomaterials (2014) 0.85
Endocytosis of PEGylated nanoparticles accompanied by structural and free energy changes of the grafted polyethylene glycol. Biomaterials (2014) 0.84
Linear topology confers in vivo gene transfer activity to polyethylenimines. Bioconjug Chem (2006) 0.83
Heterobivalent agents targeting PSMA and integrin-αvβ3. Bioconjug Chem (2014) 0.82
An acetal-based PEGylation reagent for pH-sensitive shielding of DNA polyplexes. Bioconjug Chem (2007) 0.82
Tumor-specific expression and detection of a CEST reporter gene. Magn Reson Med (2015) 0.82
Shape Control in Engineering of Polymeric Nanoparticles for Therapeutic Delivery. Biomater Sci (2015) 0.77
Nucleic-acid based gene therapeutics: delivery challenges and modular design of nonviral gene carriers and expression cassettes to overcome intracellular barriers for sustained targeted expression. J Drug Target (2012) 0.76
Shape Transformation Following Reduction-Sensitive PEG Cleavage of Polymer/DNA Nanoparticles. J Mater Chem B Mater Biol Med (2014) 0.76
Synthesis of polyethylenimine-based nanocarriers for systemic tumor targeting of nucleic acids. Methods Mol Biol (2013) 0.75